JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB142148

FK-866, NAMPT inhibitor

Be the first to review this product! Submit a review

|

(0 Publication)

MW 391.5 Da, Purity >98%. Potent, selective, non-competitive NAMPT inhibitor (Ki = 0.3 nM). Anticancer activity in vivo. Orally active.
1 Images
Chemical Structure - FK-866, NAMPT inhibitor (AB142148)
  • Chemical Structure

Lab

Chemical Structure - FK-866, NAMPT inhibitor (AB142148)

2D chemical structure image of ab142148, FK-866, NAMPT inhibitor

Key facts

CAS number

658084-64-1

Purity

>98%

Form

Solid

form

Molecular weight

391.5 Da

Molecular formula

C<sub>2</sub><sub>4</sub>H<sub>2</sub><sub>9</sub>N<sub>3</sub>O<sub>2</sub>

PubChem

6914657

Nature

Synthetic

Solubility

Soluble in DMSO to 50 mM

Soluble in ethanol to 100 mM

Biochemical name

Daporinad

Biological description

Potent, selective, non-competitive NAMPT inhibitor (Ki = 0.3 nM). Anticancer activity in vivo. Orally active.

Canonical smiles

C1CN(CCC1CCCCNC(=O)C=CC2=CN=CC=C2)C(=O)C3=CC=CC=C3

Isomeric smiles

C1CN(CCC1CCCCNC(=O)/C=C/C2=CN=CC=C2)C(=O)C3=CC=CC=C3

InChi

InChI=1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13-17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14,16-18H2,(H,26,28)/b12-11+

InChiKey

KPBNHDGDUADAGP-VAWYXSNFSA-N

IUPAC Name

(E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide

style
left-column

Complementary Products

Biochemicals

AB120503

BAPTA-AM, Ca2+ chelator

Immunocytochemistry/ Immunofluorescence - BAPTA-AM, Ca2+ chelator (AB120503)

  • 0
  • 0
Secondary Antibodies

AB150077

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488)

Immunocytochemistry/ Immunofluorescence - Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (AB150077)

  • 5
  • 20
Biochemicals

AB120914

Xestospongin C, IP3 receptor antagonist

Chemical Structure - Xestospongin C, IP3 receptor antagonist (AB120914)

  • 0
  • 0
Primary Antibodies

AB192890

Anti-LC3B antibody [EPR18709] - Autophagosome Marker

BOND RX™ Validated|RabMAb|Recombinant|KO Validated|Lab Essentials|20ul selling size

Western blot - Anti-LC3B antibody [EPR18709] - Autophagosome Marker (AB192890)

  • 5
  • 19
style
left-column

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 1914 FK-866. 1914-5 is the same size as the 5 mg size of ab142148.
style
left-column

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cytochrome P450 3A4 also called CYP3A4 is an important enzyme in the liver and intestine. It plays an important role in metabolizing around half of all drugs currently used. CYP3A4 has a mass of approximately 57 kDa. It is expressed not only in the liver and intestinal tract but also present in significant amounts in the kidneys lungs and brain. This enzyme belongs to the cytochrome P450 family which includes other key proteins involved in drug metabolism like CYP3A5.
Biological function summary

The enzyme CYP3A4 facilitates the chemical breakdown of substances. It performs oxidation reactions that convert lipophilic drugs into a more water-soluble form aiding excretion from the body. CYP3A4 is not usually part of a larger enzyme complex but it works with cofactors in the liver like NADPH-cytochrome P450 reductase to perform its function. This cooperation is essential to its role in activating and deactivating drugs which prevents toxic accumulation of substances.

Pathways

CYP3A4 influences the metabolism of drugs and the synthesis of cholesterol and other steroids. It is involved in the xenobiotic metabolism pathway which includes other proteins such as CYP2C9 and CYP2D6. CYP3A4 metabolizes various substances including hormones and some vitamins. It impacts the homeostasis of endogenously generated compounds and indirectly affects signaling pathways that involve these compounds.

CYP3A4 has associations with liver diseases and drug-induced toxicity. It also relates to drug interactions as its activity can vary widely between individuals due to genetic polymorphisms affecting drug efficacy and safety. Changes in CYP3A4 expression or function can link to conditions like liver cancer. The enzyme's activity may also influence conditions involving inflammation through its connections to the metabolism of anti-inflammatory drugs and interaction with proteins such as P-glycoprotein.
style
left-column
style
left-column

Product protocols

style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com